Author(s):
Deep Parek, Heer Patel, Devanshi Matroja
Email(s):
deepparekh0603@gmail.com , heer.dev05@gmail.com , matrojadevanshi@gmail.com
DOI:
10.52711/2231-5659.2026.00054 
Address:
Deep Parek*, Heer Patel, Devanshi Matroja
Krishna School of Pharmacy & Research (KSP), Constituent School of Drs. Kiran & Pallavi Patel Global University (KPGU), Vadodara, Gujarat, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 4,
Year - 2026
ABSTRACT:
The advent of three-dimensional (3D) printing, or additive manufacturing, has revolutionized the pharmaceutical landscape by enabling the design and fabrication of highly customized, patient-specific dosage forms. Traditional mass-production models, though efficient, often fail to accommodate inter-patient variability in physiology, genetics, and therapeutic response. 3D printing bridges this gap by allowing precise control over drug loading, release kinetics, and dosage geometry, thus advancing the paradigm of personalized and precision pharmaceutics. Various techniques such as fused deposition modeling (FDM), inkjet printing, stereolithography (SLA), and selective laser sintering (SLS) have been successfully adapted for pharmaceutical use, offering the flexibility to produce complex formulations including polypills, Oro dispersible films, microneedle patches, and implantable devices. Integration with artificial intelligence, nanotechnology, and digital health systems further enhances its potential for on-demand, decentralized manufacturing at the point of care. Despite its transformative promise, challenges persist regarding scalability, regulatory compliance, stability of thermo-labile drugs, and ethical concerns surrounding decentralized production. Nonetheless, 3D printing represents a paradigm shift toward a more patient-centric, sustainable, and technologically advanced pharmaceutical future.
Cite this article:
Deep Parek, Heer Patel, Devanshi Matroja. 3D-printed Medicines and Personalized Dosage: Shaping the Future of Precision Pharmaceutics. Asian Journal of Research in Pharmaceutical Sciences. 2026; 16(4):371-0 doi: 10.52711/2231-5659.2026.00054
Cite(Electronic):
Deep Parek, Heer Patel, Devanshi Matroja. 3D-printed Medicines and Personalized Dosage: Shaping the Future of Precision Pharmaceutics. Asian Journal of Research in Pharmaceutical Sciences. 2026; 16(4):371-0 doi: 10.52711/2231-5659.2026.00054 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2026-16-4-7
10. REFERENCE:
1. Rajendran NK, Kumar SS, Houreld NN, Abrahamse H. A review on nanoparticle-based treatment for wound healing. Journal of Drug Delivery Science and Technology. 2018 Apr 1; 44:421-30.
2. Briasoulis A, Asleh R. Cardiovascular risk prediction in older adults with the use of biomarkers. Annals of Translational Medicine. 2018 Nov; 6(Suppl 1):S50.
3. Ventola CL. Medical applications for 3D printing: current and projected uses. Pharmacy and Therapeutics. 2014 Oct; 39(10):704.
4. Garg A, Rathor M. Tablet Evolution: Exploring Cutting-edge Technologies in Formulation and Development. Asian Journal of Pharmacy and Technology. 2024; 14(4):373-8.
5. Evans SE, Harrington T, Rivero MC, Rognin E, Tuladhar T, Daly R. 2D and 3D inkjet printing of biopharmaceuticals–A review of trends and future perspectives in research and manufacturing. International Journal of Pharmaceutics. 2021 Apr 15; 599:120443.
6. Albed Alhnan M, Okwuosa TC, Sadia M, Wan KW, Ahmed W, Arafat B. Emergence of 3D printed dosage forms: opportunities and challenges. Pharmaceutical Research. 2016 Aug 1; 33(8):1817-32.
7. Karpiński TM. Selected medicines used in iontophoresis. Pharmaceutics. 2018 Oct 25; 10(4):204.
8. Fina F, Goyanes A, Gaisford S, Basit AW. Selective laser sintering (SLS) 3D printing of medicines. International Journal of Pharmaceutics. 2017 Aug 30; 529(1-2):285-93.
9. Tari T, Fekete Z, Szabó-Révész P, Aigner Z. Reduction of glycine particle size by impinging jet crystallization. International Journal of Pharmaceutics. 2015 Jan 15; 478(1):96-102.
10. Khaled SA, Burley JC, Alexander MR, Roberts CJ. Desktop 3D printing of controlled release pharmaceutical bilayer tablets. International Journal of Pharmaceutics. 2014 Jan 30; 461(1-2):105-11.
11. El Leithy ES, Abdel-Bar HM, Ali RA. Folate-chitosan nanoparticles triggered insulin cellular uptake and improved in vivo hypoglycaemic activity. International Journal of Pharmaceutics. 2019 Nov 25; 571:118708.
12. Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of tablets containing multiple drugs with defined release profiles. Int J Pharm. 2015; 494(2):643–650.
13. Trenfield SJ, Awad A, Goyanes A, Gaisford S, Basit AW. 3D printing pharmaceuticals: Drug development to frontline care. Trends Pharmacol Sci. 2018; 39(5):440–451.
14. Aminu N, Chan SY, Lee HK. Pediatric drug formulations: Opportunities and challenges with 3D printing. Int J Pharm. 2020; 587:119648.
15. Hemanth KG, Hemamanjushree S, Abhinaya N, Pai R, Pai GK. 3D printing: A review on technology, role in novel dosage forms and regulatory perspective. Res J Pharm Technol. 2021; 14(1):562–572.
16. Aprecia Pharmaceuticals. SPRITAM® (levetiracetam) tablets: The first FDA-approved medicine manufactured using 3D printing technology [Internet]. Blue Ash (OH): Aprecia Pharmaceuticals; 2015
17. Awad A, Fina F, Goyanes A, Gaisford S, Basit AW. 3D printing: Principles and pharmaceutical applications. Int J Pharm. 2018; 548(1): 188–194.
18. Gioumouxouzis CI, Katsamenis OL, Bouropoulos N, Fatouros DG. 3D printing in pharmaceutical research: Applications and perspectives. Pharmaceutics. 2020; 12(6): 575.
19. Goyanes A, Buanz ABM, Basit AW, Gaisford S. Fabrication of modified-release tablets using 3D printing (FDM). Int J Pharm. 2014; 476(1–2): 88–92.
20. Goyanes A, Wang J, Buanz A, Martínez-Pacheco R, Telford R, Gaisford S, Basit AW. 3D printing of medicines: Engineering novel oral devices with unique design and drug release characteristics. J Control Release. 2015; 213: 75–85.
21. Jamróz W, Szafraniec J, Kurek M, Jachowicz R. 3D printing in pharmaceutical and medical applications – Recent achievements and challenges. Pharm Res. 2017; 34(8):1766–1776.
22. Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of five-in-one dose combination polypills. Int J Pharm. 2015; 494(2): 643–650.
23. Skowyra J, Pietrzak K, Alhnan MA. Fabrication of extended-release patient-tailored tablets via fused deposition modeling. Eur J Pharm Sci. 2015; 68:11–17.
24. Uddin MJ, Scoutaris N, Bradley M, Shakesheff KM, Douroumis D. 3D printed microneedles for transdermal drug delivery. Int J Pharm. 2019; 494(2): 593–602.
25. Uddin MJ, Scoutaris N, Douroumis D. Patient-centric drug design and 3D printing. Expert Opin Drug Deliv. 2020; 17(2):145–147.
26. Zhou J, Liu Y, Huang L, Tan J. Advances in 3D printed implantable devices for controlled drug delivery. J Control Release. 2020; 322:1–17.
27. Trenfield SJ, Awad A, Madla CM, Goyanes A, Gaisford S, Basit AW. Shaping the future: 3D printing of oral medicines. Adv Drug Deliv Rev. 2018; 132:262–268.
28. Okwuosa TC, Pereira BC, Arafat B, Alhnan MA. Fabricating oral tablets via 3D printing: Emerging technologies and future prospects. J Pharm Sci. 2017; 106(11):3070–3078.
29. Yi HG, Choi YJ, Kang KS. Current advances in 3D bioprinting: The role of biomaterials. Int J Mol Sci. 2019; 20(23):6140.
30. Alhnan MA, Okwuosa TC, Sadia M, Wan KW, Ahmed W, Arafat B. Emergence of 3D printed dosage forms: Opportunities and challenges. Pharm Res. 2016; 33(8): 1817–1832.
31. Awad A, Trenfield SJ, Goyanes A, Gaisford S, Basit AW. 3D printing: Principles and pharmaceutical applications of selective laser sintering. Int J Pharm. 2018; 548(1): 586–596.
32. Shaikh JS, Akbari B. Transfersomes in advanced drug delivery: A comprehensive review of design, mechanism, and clinical applications. Asian J Pharm Technol. 2025; 15(4): 395–4.
33. Ayyoubi S, Taymouri S, Varshosaz J, Taheri A, Shokri J. 3D printing in pharmaceutics: A new tool for designing personalized medicine. Iran J Pharm Res. 2021; 20(3): 221–233.
34. Gioumouxouzis CI, Karavasili C, Fatouros DG. Recent advances in pharmaceutical 3D printing: From proof of concept to clinical applications. Int J Pharm. 2021; 601:120586.
35. Goyanes A, Buanz AB, Hatton GB, Gaisford S, Basit AW. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur J Pharm Biopharm. 2015; 89:157–162.
36. Kantor TG, Goyanes A, Gaisford S, Basit AW, Trenfield SJ. Regulatory aspects of 3D printing in pharmaceutics: The FDA perspective. Adv Drug Deliv Rev. 2021; 173:150–161.
37. Pawar PP, Phadtare DG. Acoustic mediated drug delivery system. Res J Pharm Dosage Form Tech. 2016; 8(1):55–65.
38. Khaled SA, Burley JC, Alexander MR, Roberts CJ. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. J Control Release. 2015; 217:308–314.
39. Kjar A, Huang Y. Application of micro-scale 3D printing in pharmaceutics. Pharmaceutics. 2019; 11(8):390.
40. Li Q, Guan X, Cui M, Zhu Z, Chen K, Wen H, Pan W. Preparation and investigation of controlled-release glipizide novel oral device with three-dimensional printing. Int J Pharm. 2017; 525(1):5–11.
41. Martinez PR, Goyanes A, Basit AW, Gaisford S. Fabrication of drug-loaded hydrogels by 3D printing for oral drug delivery. Int J Pharm. 2018; 539(1–2):179–185.
42. Pagare PK, Satpute CS, Jadhav VM, Kadam VJ. BioSilicon: A novel drug delivery system. Res J Pharm Technol. 2012; 5(8):1107–1111.
43. Mohammed DF, Elsawy MA, Faraj JA, Mohammed SMM. Controlled drug release from hydrogel formulations for the localised delivery of anticancer agents to solid tumors. Res J Pharm Technol. 2023; 16(4):1797–1805.
44. Norman J, Madurawe RD, Moore CMV, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv Drug Deliv Rev. 2017; 108:39–50.
45. Preis M, Öblom H. 3D-printed drugs for children—are we ready yet? AAPS PharmSciTech. 2017; 18(2):303–308.
46. Prasad LK, Smyth H. 3D printing technologies for drug delivery: A review. Drug Dev Ind Pharm. 2016; 42(7):1019–1031.
47. Scoutaris N, Ross SA, Douroumis D. 3D printed “polypill”: The future of personalized medicine? Pharmaceutics. 2018; 10(4):204.
48. Trenfield SJ, Awad A, Madla CM, Goyanes A, Gaisford S, Basit AW. Shaping the future: Recent advances of 3D printing in drug delivery and healthcare. Expert Opin Drug Deliv. 2019; 16(10):1081–1094.
49. Uddin MJ, Scoutaris N, Economidou SN, Gaisford S, Basit AW, Douroumis D. 3D printed microneedles for transdermal drug delivery: A review. Pharm Res. 2019; 36(3):41.
50. Vuddanda PR, Alomari M, Dodoo CC, Trenfield SJ, Velaga S, Basit AW, Gaisford S. Personalisation of warfarin therapy using 3D printing. Eur J Pharm Sci. 2018; 117:117–123.
51. Quazi A, Pange SS, Alkunte AS, Lokhande S. Design, development and optimization of mini-tablet filled capsule system of terbutaline sulphate for controlled drug release. Res J Pharm Technol. 2013; 6(12):1350–1356.
52. Khan SW, Parab I. A detailed review on 3D bioprinting and its application in pharmaceutical science. Int J Technol. 2023; 13(1):57–67.
53. Kumar DV, Palanichamy S, Swamy GK, Kumar UA. Formulation and evaluation of silymarin floating drug delivery system. Res J Pharm Technol. 2011; 4(3):393–397.
54. Saumya S, Anbuselvan A, Poorva S, Priya G. A review on 3D printing techniques and scaffolds for auricular cartilage reconstruction. Res J Pharm Technol. 2018; 11(9):4179–4186.
55. Abdulkhaleq NM, Ghareeb MM. 3D printing of baclofen gastro-floating drug delivery systems: A comparison study with in vitro and in vivo evaluation. Res J Pharm Technol. 2023; 16(1):363–372.
56. Mankar SD, Kale C, Kanchan J. 3D printing technology—A computer aided design: A review. Res J Sci Technol. 2019; 11(3):217–224.
57. Kousar S, Ahad HA, Chinthaginjala H, Babafakruddin P, Lakunde J, Tarun K. Gas generating floating tablets: A quick literature review for the scholars. Asian J Res Chem. 2022; 15(2):171–175.